ENGINEERING STRATEGIES FOR TCR AND CAR-T CELL THERAPIES
Terms and Conditions | Privacy Policy
† You may still receive emails from us regarding any current registrations or orders.
CAR-T and T-cell receptor (TCR) cell therapies are some of the most exciting emerging therapies on the market today, and their engineering strategies are crucial. This whitepaper discusses recent developments in CAR and TCR engineering and the overlap with antibody engineering, including:
Please consider joining us at the upcoming:
Antibody Engineering & Therapeutics US
December 13-17, 2020 * San Diego, CA
Learn More at: https://informaconnect.com/antibody-engineering-therapeutics/